Threshold dose for discrimination of nicotine via cigarette smoking

Psychopharmacology

Volumn 233, Issue 12, 2016, Pages 2309-2317

  Perkins, Kenneth A ^a   Kunkle, Nicole ^a   Karelitz, Joshua L ^a   Michael, Valerie C ^a   Donny, Eric C ^b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Choice; Cigarette smoking; Discrimination; Nicotine; Subjective effects; Threshold

Indexed keywords

NICOTINE; TAR;

ADULT; ANALYTICAL PARAMETERS; ARTICLE; CIGARETTE EXPOSURE; COMPARATIVE STUDY; DOSE RESPONSE; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; MALE; NICOTINE CONTENT; PERCEPTIVE DISCRIMINATION; PRIORITY JOURNAL; SMOKING; SMOKING AND SMOKING RELATED PHENOMENA; SMOKING CESSATION; SMOKING HABIT; THRESHOLD DOSE; ULTRALOW CIGARETTE; DECISION MAKING; DISCRIMINATION LEARNING; DRUG EFFECTS; PHYSIOLOGY; PSYCHOLOGY; TOBACCO; YOUNG ADULT;

ADULT; CHOICE BEHAVIOR; DISCRIMINATION LEARNING; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; NICOTINE; SMOKING; TOBACCO PRODUCTS; YOUNG ADULT;

EID: 84962159762     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-016-4281-2     Document Type: Article

References (60)

1. American Psychiatric Association (APA) (2013) Diagnostic and statistical manual—v. American Psychiatric Association, Washington DC
2. Benowitz NL, Henningfield JE (1994) Establishing a nicotine threshold for addiction. New Engl J Med 331:123–125
3. Benowitz NL, Hall SM, Herning RI, Jacob P, Jones RT, Osman A-L (1983) Smokers of low-yield cigarettes do not consume less nicotine. New Engl J Med 309:139–142
4. Blank MD, Disharoon S, Eissenberg T (2009) Comparison of methods for measurement of smoking behavior: mouthpiece-based computerized devices versus direct observation. Nicotine Tob Res 11:896–903
5. Breslau N, Kilbey MM, Andreski P (1994) DSM-IIIR nicotine dependence in young adults: prevalence, correlates and associated psychiatric disorders. Addiction 89:743–754
6. Brody AL, Mandelkern MA, Costello MR, Abrams AL, Scheibal D, Farahi J et al (2009) Brain nicotinic acetylcholine receptor occupancy: effect of smoking a denicotinized cigarette. Int J Neuropsychopharmacol 12:305–312
7. Butschky MF, Bailey D, Henningfield JE, Pickworth WB (1995) Smoking with nicotine delivery decreases withdrawal in 12-hour abstinent smokers. Pharmacol Biochem Behav 50:91–96
8. Chait LE, Evans SM, Grant KA, Kamien JB, Johanson CE, Schuster CR (1988) The discriminative stimulus and subjective effects of smoked marijuana in humans. Psychopharmacology (Berl) 94:206–212
9. Donny EC, Houtsmuller E, Stitzer ML (2007) Smoking in the absence of nicotine: behavioral, subjective and physiological effects over 11 days. Addiction 102:324–334
10. Donny EC, Denlinger RL, Tidey JW et al (2015) Randomized trial of reduced-nicotine standards for cigarettes. New Engl J Med 373:1340–1349
11. Duke AN, Johson MW, Reissig CJ, Griffiths RR (2015) Nicotine reinforcement in never-smokers. Psychopharmacology (Berl) 232:4243–4252
12. Glennon RA, Young R (2011) Drug discrimination: application to medicinal chemistry and drug studies. Wiley, New York
13. Goodwin AK, Hiranita T, Paule MG (2015) The reinforcing effects of nicotine in humans and nonhuman primates: a review of intravenous self-administration evidence and future directions for research. Nicotine Tob Res 17:1297–1310
14. U.S. Govt (2009) Family Smoking Prevention and Tobacco Control Act, Pub. L. No. 111–31; http://www.gpo.gov/fdsys/pkg/PLAW-111publ31/pdf/PLAW-111publ31.pdf
15. Grebenstein PE, Burroughs D, Roiko SA, Pentel PR, LeSage MG (2015) Predictors of the nicotine reinforcement threshold, compensation, and elasticity of demand in a rodent model of nicotine reduction policy. Drug Alc Depend 151:181–193
16. Gu X, Lohrenz T, Salas R et al (2015) Belief about nicotine selectively modulates value and reward prediction error signals in smokers. Proc Natl Acad Sci USA 112:2539–2544
17. Harvey DM, Yasar S, Heishman SJ, Panlilio LV, Henningfield JE, Goldberg SR (2004) Nicotine serves as an effective reinforcer of intravenous drug-taking behavior in human cigarette smokers. Psychopharmacology (Berl) 175:134–142
18. Hasenfratz M, Jacober A, Battig K (1993) Smoking-related subjective and physiological changes: pre- to postpuff and pre- to postcigarette. Pharmacol Biochem Behav 46:527–534
19. Hatsukami DK, Pickens RW, Svikis DS, Hughes JR (1988) Smoking topography and nicotine blood levels. Addict Behav 13:91–95
20. Hatsukami DK, Perkins KA, LeSage MG, Ashley DL, Henningfield JE, Benowitz NL, Backinger C, Zeller M (2010) Nicotine reduction revisited: science and future directions. Tob Control 19:436–445
21. Hatsukami DK, Biener L, Leischow SJ, Zeller MR (2012) Tobacco and nicotine product testing. Nicotine Tob Res 14:7–17
22. Hatsukami DK, Benowitz NL, Donny E, Henningfield J, Zeller MR (2013a) Nicotine reduction: Strategic research plan. Nicotine Tob Res 15:1003–1013
23. Hatsukami DK, Heishman SJ, Vogel RI, Denlinger RL et al (2013b) Dose-response effects of Spectrum research cigarettes. Nicotine Tob Res 15:1113–1121
24. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom K-O (1991) The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 86:1119–1127
25. Hecht SS (2012) Research opportunities related to establishing standards for tobacco products under the Family Smoking Prevention and Tobacco Control Act. Nicotine Tob Res 14:18–28
26. Henningfield JE, Keenan RM (1993) Nicotine delivery kinetics and abuse liability. J Consult Clin Psychol 61:743–750
27. Henningfield JE, Kozlowski LT, Benowitz NL (1994) A proposal to develop meaningful labeling for cigarettes. JAMA 272:312–314
28. Hoffmann AC, Evans SE (2013) Abuse potential of non-nicotine tobacco smoke constituents: acetaldehyde, nornicotine, cotinine, and anabasine. Nicotine Tob Res 15:622–632
29. Holtzman SG (1990) Discriminative stimulus effects of drugs: relationship to potential for abuse. In: Modern Methods in Pharmacology, vol 6. Wiley-Liss, Inc, New York, pp 193–210
30. Hughes JR, Hatsukami DK (1986) Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry 43:289–294
31. Jackson A, Stephens DN, Duka T (2001) A low dose alcohol drug discrimination in social drinkers: relationship with subjective effects. Psychopharmacology (Berl) 157:411–420
32. Jarvis MJ, Boreham R, Primatesta P, Feyerabend C, Bryant A (2001) Nicotine yield from machine-smoked cigarettes and nicotine intakes in smokers: evidence from a representative population. J of NCI 93:134–138
33. Johanson C-E (1991) Discriminative stimulus effects of psychomotor stimulants and benzodiazepines in humans. In: Glennon RA, Jarbe TUC, Frankenheim J (eds) Drug discrimination: applications to drug abuse research, vol 116, NIDA Research Monograph. U.S. Government Printing Office, Washington DC, pp 181–196
34. June KM, Norton KJ, Rees VW, O’Connor RJ (2012) Influence of measurement setting and home smoking policy on smoking topography. Addict Behav 37:42–46
35. Marian C, O’Connor RJ, Djordjevic MV, Rees VW, Hatsukami DK, Shields PG (2009) Reconciling human smoking behavior and machine smoking patterns: implications for understanding smoking behavior and the impact on laboratory studies. Cancer Epid Biomarkers Prev 18:3305–3320
36. Mooney M, Green C, Hatsukami D (2006) Nicotine self-administration: cigarettes versus nicotine gum diurnal topography. Hum Psychopharmacol 21:539–548
37. Mumford GK, Evans SM, Kaminski BJ, Preston KL, Sannerud CA, Silverman K, Griffiths RR (1994) Discriminative stimulus and subjective effects of theobromine and caffeine in humans. Psychopharmacology (Berl) 115:1–8
38. Perkins KA (2009) Discriminative stimulus effects of nicotine in humans. In: Henningfield JE, London E, Pogun S (eds) Nicotine psychopharmacology. Springer-Verlag, New York, pp 369–400
39. Perkins KA (2011) Nicotine discrimination in humans. Chapter 15. In: Glennon RA, Young R (eds) Drug discrimination: application to medicinal chemistry and drug studies. Wiley, New York, pp 463–481
40. Perkins KA, DiMarco A, Grobe JE, Scierka A, Stiller RL (1994) Nicotine discrimination in male and female smokers. Psychopharmacology (Berl) 116:407–413
41. Perkins KA, Grobe JE, Weiss D, Fonte C, Caggiula A (1996) Nicotine preference in smokers as a function of smoking abstinence. Pharmacol Biochem Behav 55:257–263
42. Perkins KA, Fonte C, Sanders M, Meeker J, Wilson A (2001) Threshold doses for nicotine discrimination in smokers and nonsmokers. Psychopharmacology (Berl) 155:163–170
43. Perkins KA, Karelitz JL, Giedgowd GE, Conklin CA (2012) The reliability of puff topography and subjective responses during ad lib smoking of a single cigarette. Nicotine Tob Res 14:490–494
44. Perkins KA, Kunkle N, Michael VC, Karelitz JL, Donny EC (in press). Assessing discrimination of nicotine in humans via cigarette smoking. Nicotine Tob Res. (in press).
45. Pittenger ST, Bevins RA (2013) Interoceptive conditioning in rats: effects of using a single training dose or a set of 5 different doses of nicotine. Pharmacol Biochem Behav 114:82–89
46. Preston KL (1991) Drug discrimination methods in human drug abuse liability evaluation. Br J Addiction 86:1587–1594
47. Preston KL, Bigelow GE (1998) Opioid discrimination in humans: discriminative and subjective effects of progressively lower training dose. Behav Pharmacol 9:533–543
48. Rose JE (2006) Nicotine and nonnicotine factors in cigarette addiction. Psychopharmacology (Berl) 184:274–285
49. Rush CR, Critchfield TS, Troisi JR, Griffiths RR (1995) Discriminative stimulus effects of diazepam and buspirone in normal volunteers. J Exper Anal Behav 63:277–294
50. Shoaib M, Stolerman IP (1996) Brain sites mediating the discriminative stimulus effects of nicotine in rats. Behav Brain Res 78:183–188
51. Smith JW, Stolerman IP (2009) Recognising nicotine: the neurobiological basis of nicotine discrimination. In: Henningfield JE, London E, Pogun S (eds) Nicotine Psychopharmacology. Springer-Verlag, New York, pp 295–333
52. Sofuoglu M, LeSage MG (2012) The reinforcement threshold for nicotine as a target for tobacco control. Drug Alc Depend 125:1–7
53. Sofuoglu M, Yoo S, Hill KP, Mooney M (2008) Self-administration of intravenous nicotine in male and female cigarette smokers. Neuropsychopharmacol 33:715–720
54. SRNT subcommittee (2002) Biochemical verification of tobacco use and cessation. Nicotine Tob Res 4:149–159
55. St. Charles FK, Kabbani AA, Borderding MF (2010) Estimating tar and nicotine exposure: human smoking versus machine generated smoke yields. Reg Tox Pharmacol 56:100–110
56. Stolerman IP (1989) Discriminative stimulus effects of nicotine in rats trained under different schedules of reinforcement. Psychopharmacology (Berl) 97:131–138
57. Strasser AA, Ashare RL, Kozlowski LT, Pickworth WB (2005) The effect of filter vent blocking and smoking topography on carbon monoxide levels in smokers. Pharmacol Biochem Behav 82:320–329
58. Strasser AA, Ashare RL, Kaufman M, Tang KZ, Mesaros AC, Blair IA (2013) The effect of menthol on cigarette smoking behaviors, biomarkers and subjective responses. Cancer Epid Biomarkers Prev 22:382–389
59. Takada K (1996) Drug discrimination studies in humans: a review of methodologies. Meth Find Exp Clin Pharmacol 18(suppl 1):187–196
60. U.S. Department of Health and Human Services (USDHHS) (2010) How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease. A report of the surgeon general. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta